OLSALAZINE
- Product Name
- OLSALAZINE
- CAS No.
- 15722-48-2
- Chemical Name
- OLSALAZINE
- Synonyms
- azodisal;Ph-CJ-91B;Dipentium;OLSALAZINE;Olsalazine D6;Olsalazine-13C6;Olsalazine 13C12;c.i.mordantyellow5;OLSALAZINE USP/EP/BP;OLSALAZINE 15722-48-2
- CBNumber
- CB2211118
- Molecular Formula
- C14H10N2O6
- Formula Weight
- 302.24
- MOL File
- 15722-48-2.mol
OLSALAZINE Property
- Melting point:
- >300 °C(Solv: acetic acid (64-19-7); water (7732-18-5))
- Boiling point:
- 443.29°C (rough estimate)
- Density
- 1.3578 (rough estimate)
- refractive index
- 1.6500 (estimate)
- pka
- 2.40±0.10(Predicted)
- form
- Solid
- color
- Light yellow to yellow
- Water Solubility
- 11.49ug/L(25 ºC)
- CAS DataBase Reference
- 15722-48-2(CAS DataBase Reference)
N-Bromosuccinimide Price
- Product number
- API0003678
- Product name
- OLSALAZINE
- Purity
- 95.00%
- Packaging
- 25MG
- Price
- $191.1
- Updated
- 2021/12/16
- Product number
- ND34110
- Product name
- Olsalazine-d3,15Nsodium
- Packaging
- 5mg
- Price
- $1900
- Updated
- 2021/12/16
- Product number
- 1653A
- Product name
- Olsalazine
- Packaging
- 50mg
- Price
- $79
- Updated
- 2021/12/16
- Product number
- 1653A
- Product name
- Olsalazine
- Packaging
- 250mg
- Price
- $195
- Updated
- 2021/12/16
- Product number
- 1653A
- Product name
- Olsalazine
- Packaging
- 1g
- Price
- $349
- Updated
- 2021/12/16
OLSALAZINE Chemical Properties,Usage,Production
Uses
Anti-inflammatory (gastrointestinal).
Definition
ChEBI: An azobenzene that consists of two molecules of 4-aminosalicylic acid joined by an azo linkage. A prodrug for mesalazine, an anti-inflammatory drug, it is used (as the disodium salt) in the treatment of inflammatory bowel disease.
Indications
Olsalazine is approved for maintenance of remission of ulcerative colitis, but a commonly reported side effect is a paradoxical increase in diarrhea. The U. S. Food and Drug Administration (FDA) has approved balsalazide disodium (Colazal) as a treatment of mild to moderately active ulcerative colitis.
brand name
Dipentum (UCB).
Mechanism of action
Olsalazine is approved for maintenance of remission of ulcerative colitis, but a commonly reported side effect is a paradoxical increase in diarrhea. The U. S. Food and Drug Administration (FDA) has approved balsalazide disodium (Colazal) as a treatment of mild to moderately active ulcerative colitis.
Veterinary Drugs and Treatments
Olsalazine is used for treatment of dogs with chronic colitis that either cannot tolerate the adverse effects associated with sulfasalazine or the response to sulfasalazine has been ineffective.
OLSALAZINE Preparation Products And Raw materials
Raw materials
Preparation Products
OLSALAZINE Suppliers
- Tel
- 021-50182298 021-50180596
- Fax
- +86-21-57758967
- sales@boylechem.com
- Country
- China
- ProdList
- 2208
- Advantage
- 55
- Tel
- 021-60345187 13671753212
- Fax
- 021-34702061
- lzz841106@aliyun.com
- Country
- China
- ProdList
- 10274
- Advantage
- 55
- Tel
- Fax
- -
- xg01_gj@163.com
- Country
- China
- ProdList
- 9484
- Advantage
- 50
- Tel
- 1-516-6625404
- Fax
- 1-516-927-0118
- support@alfa-chemistry.com
- Country
- United States
- ProdList
- 9171
- Advantage
- 60
- Tel
- 0431-0431-80514535 19917294565
- et@chemextension.com
- Country
- China
- ProdList
- 3980
- Advantage
- 55
- Tel
- 025-83453382-8005
- Fax
- 025-83453382
- sale@parabiochem.com
- Country
- China
- ProdList
- 9595
- Advantage
- 55
- Tel
- 571-89925085
- Fax
- 0086-571-89925065
- sales@amadischem.com
- Country
- China
- ProdList
- 131957
- Advantage
- 58
- Tel
- 177-7179-1433 17771741533
- Fax
- 027-62437337
- 1228159977@qq.com
- Country
- China
- ProdList
- 1298
- Advantage
- 58
- Tel
- 025-58859352 18068836627
- Fax
- 02557626880
- sales01@aikonchem.com
- Country
- China
- ProdList
- 15084
- Advantage
- 58
- Tel
- 027-87466105 15377573527
- 2678564200@qq.com
- Country
- China
- ProdList
- 17987
- Advantage
- 58
View Lastest Price from OLSALAZINE manufacturers
- Product
- OLSALAZINE 15722-48-2
- Price
- US $1.00/KG
- Min. Order
- 1KG
- Purity
- 95-99%
- Supply Ability
- 1ton
- Release date
- 2020-01-03